{
  "paper_id": "PMC11621391",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11621391/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1. An example of eye with hyperTD with progression.",
      "caption": "A single small hyperTD (white arrow) is detected on the baseline en face OCT (A). The corresponding horizontal OCT B-scan (E) shows choroidal hypertransmission and a small region of RPE disruption, but no overlying photoreceptor degeneration (white asterisk). The criteria for iRORA are not met at baseline on OCT. Fourteen months from baseline, multiple small hyperTDs (white circle) are evident with a progression to iRORA (B and F). Six months later (20 months from baseline), these small hyperTDs coalesced and developed into large hyperTDs with a hyporeflective core (donut; yellow arrow) on the en face OCT (C) and iRORA (yellow asterisk) on the corresponding B-scan (G). At the final follow-up (26 months from baseline), a large hyperTD without a hyporeflective core (yellow arrow) is evident on the en face OCT (D) with cRORA (yellow asterisk) on the corresponding B-scan (H). This eye is deemed a progression eye.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/73e1dfb3d190/41433_2024_3338_Fig1_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/73e1dfb3d190/41433_2024_3338_Fig1_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/73e1dfb3d190/41433_2024_3338_Fig1_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/73e1dfb3d190/41433_2024_3338_Fig1_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/73e1dfb3d190/41433_2024_3338_Fig1_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11621391/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/73e1dfb3d190/41433_2024_3338_Fig1_HTML.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Fig. 2. An example of eye with hyperTDs with progression.",
      "caption": "Three medium hyperTDs (white arrows) are detected at baseline on the en face OCT (A). None of the hyperTD lesions meet the criteria for iRORA and one of the lesions shows in B. At the follow-up visit, two of the baseline hyperTDs persisted (yellow arrows) on the en face OCT (C). Two new hyperTDs (yellow sharp and yellow asterisk) are also noted on the en face OCT (C) with iRORA (yellow sharp and yellow asterisk) on the B-scan (D). This eye is deemed a progression eye.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/ced5bc3a96b7/41433_2024_3338_Fig2_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/ced5bc3a96b7/41433_2024_3338_Fig2_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/ced5bc3a96b7/41433_2024_3338_Fig2_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/ced5bc3a96b7/41433_2024_3338_Fig2_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/ced5bc3a96b7/41433_2024_3338_Fig2_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11621391/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a734/11621391/ced5bc3a96b7/41433_2024_3338_Fig2_HTML.jpg"
    }
  },
  "claims": [
    {
      "sentence": "No hyperTD (n = 121 eyes)\nSmall hyperTD (n = 6 eyes)\nMedium hyperTD (n = 11 eyes)\nLarge hyperTD (n = 7 eyes)\n\nP-value\n\n\n\nStable, No. (%)\n108 (89.3)\n0 (0)\n1 (9.1)\n1 (14.3)\n<0.001\n\n\nProgression to or development of iRORA or cRORA, No. (%)\n13 (10.7)\n5 (83.3)\n9 (81.8)\n6 (85.7)\n\n\nRegression, No. (%)\nNA\n1 (16.7)\n1 (9.1)\n0 (0)\n\n\n\nOpen in a new tab\ncRORA complete retinal pigment epithelial and outer retinal atrophy, GLD greatest linear dimension, hyperTD hypertransmission defect, iRORA incomplete retinal pigment epithelial and outer retinal atrophy, large hyperTD GLD ≥ 250 µm, medium hyperTD GLD 125–249 µm, NA not available, No. number, small hyperTD GLD 63–124 µm.Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "This eye is deemed a progression eye.Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "No hyperTD (n = 121 eyes)\nSmall hyperTD (n = 6 eyes)\nMedium hyperTD (n = 11 eyes)\nLarge hyperTD (n = 7 eyes)\n\nP-value\n\n\n\nStable, No. (%)\n108 (89.3)\n0 (0)\n1 (9.1)\n1 (14.3)\n<0.001\n\n\nProgression to or development of iRORA or cRORA, No. (%)\n13 (10.7)\n5 (83.3)\n9 (81.8)\n6 (85.7)\n\n\nRegression, No. (%)\nNA\n1 (16.7)\n1 (9.1)\n0 (0)\n\n\n\nOpen in a new tab\ncRORA complete retinal pigment epithelial and outer retinal atrophy, GLD greatest linear dimension, hyperTD hypertransmission defect, iRORA incomplete retinal pigment epithelial and outer retinal atrophy, large hyperTD GLD ≥ 250 µm, medium hyperTD GLD 125–249 µm, NA not available, No. number, small hyperTD GLD 63–124 µm.Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "This eye is deemed a progression eye.Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "No hyperTD (n = 121 eyes)\nSmall hyperTD (n = 6 eyes)\nMedium hyperTD (n = 11 eyes)\nLarge hyperTD (n = 7 eyes)\n\nP-value\n\n\n\nStable, No. (%)\n108 (89.3)\n0 (0)\n1 (9.1)\n1 (14.3)\n<0.001\n\n\nProgression to or development of iRORA or cRORA, No. (%)\n13 (10.7)\n5 (83.3)\n9 (81.8)\n6 (85.7)\n\n\nRegression, No. (%)\nNA\n1 (16.7)\n1 (9.1)\n0 (0)\n\n\n\nOpen in a new tab\ncRORA complete retinal pigment epithelial and outer retinal atrophy, GLD greatest linear dimension, hyperTD hypertransmission defect, iRORA incomplete retinal pigment epithelial and outer retinal atrophy, large hyperTD GLD ≥ 250 µm, medium hyperTD GLD 125–249 µm, NA not available, No. number, small hyperTD GLD 63–124 µm.Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "This eye is deemed a progression eye.Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "No hyperTD (n = 121 eyes)\nSmall hyperTD (n = 6 eyes)\nMedium hyperTD (n = 11 eyes)\nLarge hyperTD (n = 7 eyes)\n\nP-value\n\n\n\nStable, No. (%)\n108 (89.3)\n0 (0)\n1 (9.1)\n1 (14.3)\n<0.001\n\n\nProgression to or development of iRORA or cRORA, No. (%)\n13 (10.7)\n5 (83.3)\n9 (81.8)\n6 (85.7)\n\n\nRegression, No. (%)\nNA\n1 (16.7)\n1 (9.1)\n0 (0)\n\n\n\nOpen in a new tab\ncRORA complete retinal pigment epithelial and outer retinal atrophy, GLD greatest linear dimension, hyperTD hypertransmission defect, iRORA incomplete retinal pigment epithelial and outer retinal atrophy, large hyperTD GLD ≥ 250 µm, medium hyperTD GLD 125–249 µm, NA not available, No. number, small hyperTD GLD 63–124 µm.Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "This eye is deemed a progression eye.Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "No hyperTD (n = 121 eyes)\nSmall hyperTD (n = 6 eyes)\nMedium hyperTD (n = 11 eyes)\nLarge hyperTD (n = 7 eyes)\n\nP-value\n\n\n\nStable, No. (%)\n108 (89.3)\n0 (0)\n1 (9.1)\n1 (14.3)\n<0.001\n\n\nProgression to or development of iRORA or cRORA, No. (%)\n13 (10.7)\n5 (83.3)\n9 (81.8)\n6 (85.7)\n\n\nRegression, No. (%)\nNA\n1 (16.7)\n1 (9.1)\n0 (0)\n\n\n\nOpen in a new tab\ncRORA complete retinal pigment epithelial and outer retinal atrophy, GLD greatest linear dimension, hyperTD hypertransmission defect, iRORA incomplete retinal pigment epithelial and outer retinal atrophy, large hyperTD GLD ≥ 250 µm, medium hyperTD GLD 125–249 µm, NA not available, No. number, small hyperTD GLD 63–124 µm.Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "This eye is deemed a progression eye.Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "No hyperTD (n = 121 eyes)\nSmall hyperTD (n = 6 eyes)\nMedium hyperTD (n = 11 eyes)\nLarge hyperTD (n = 7 eyes)\n\nP-value\n\n\n\nStable, No. (%)\n108 (89.3)\n0 (0)\n1 (9.1)\n1 (14.3)\n<0.001\n\n\nProgression to or development of iRORA or cRORA, No. (%)\n13 (10.7)\n5 (83.3)\n9 (81.8)\n6 (85.7)\n\n\nRegression, No. (%)\nNA\n1 (16.7)\n1 (9.1)\n0 (0)\n\n\n\nOpen in a new tab\ncRORA complete retinal pigment epithelial and outer retinal atrophy, GLD greatest linear dimension, hyperTD hypertransmission defect, iRORA incomplete retinal pigment epithelial and outer retinal atrophy, large hyperTD GLD ≥ 250 µm, medium hyperTD GLD 125–249 µm, NA not available, No. number, small hyperTD GLD 63–124 µm.Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "This eye is deemed a progression eye.Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "No hyperTD (n = 121 eyes)\nSmall hyperTD (n = 6 eyes)\nMedium hyperTD (n = 11 eyes)\nLarge hyperTD (n = 7 eyes)\n\nP-value\n\n\n\nStable, No. (%)\n108 (89.3)\n0 (0)\n1 (9.1)\n1 (14.3)\n<0.001\n\n\nProgression to or development of iRORA or cRORA, No. (%)\n13 (10.7)\n5 (83.3)\n9 (81.8)\n6 (85.7)\n\n\nRegression, No. (%)\nNA\n1 (16.7)\n1 (9.1)\n0 (0)\n\n\n\nOpen in a new tab\ncRORA complete retinal pigment epithelial and outer retinal atrophy, GLD greatest linear dimension, hyperTD hypertransmission defect, iRORA incomplete retinal pigment epithelial and outer retinal atrophy, large hyperTD GLD ≥ 250 µm, medium hyperTD GLD 125–249 µm, NA not available, No. number, small hyperTD GLD 63–124 µm.Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "This eye is deemed a progression eye.Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "No hyperTD (n = 121 eyes)\nSmall hyperTD (n = 6 eyes)\nMedium hyperTD (n = 11 eyes)\nLarge hyperTD (n = 7 eyes)\n\nP-value\n\n\n\nStable, No. (%)\n108 (89.3)\n0 (0)\n1 (9.1)\n1 (14.3)\n<0.001\n\n\nProgression to or development of iRORA or cRORA, No. (%)\n13 (10.7)\n5 (83.3)\n9 (81.8)\n6 (85.7)\n\n\nRegression, No. (%)\nNA\n1 (16.7)\n1 (9.1)\n0 (0)\n\n\n\nOpen in a new tab\ncRORA complete retinal pigment epithelial and outer retinal atrophy, GLD greatest linear dimension, hyperTD hypertransmission defect, iRORA incomplete retinal pigment epithelial and outer retinal atrophy, large hyperTD GLD ≥ 250 µm, medium hyperTD GLD 125–249 µm, NA not available, No. number, small hyperTD GLD 63–124 µm.Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "This eye is deemed a progression eye.Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "No hyperTD (n = 121 eyes)\nSmall hyperTD (n = 6 eyes)\nMedium hyperTD (n = 11 eyes)\nLarge hyperTD (n = 7 eyes)\n\nP-value\n\n\n\nStable, No. (%)\n108 (89.3)\n0 (0)\n1 (9.1)\n1 (14.3)\n<0.001\n\n\nProgression to or development of iRORA or cRORA, No. (%)\n13 (10.7)\n5 (83.3)\n9 (81.8)\n6 (85.7)\n\n\nRegression, No. (%)\nNA\n1 (16.7)\n1 (9.1)\n0 (0)\n\n\n\nOpen in a new tab\ncRORA complete retinal pigment epithelial and outer retinal atrophy, GLD greatest linear dimension, hyperTD hypertransmission defect, iRORA incomplete retinal pigment epithelial and outer retinal atrophy, large hyperTD GLD ≥ 250 µm, medium hyperTD GLD 125–249 µm, NA not available, No. number, small hyperTD GLD 63–124 µm.Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "This eye is deemed a progression eye.Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "No hyperTD (n = 121 eyes)\nSmall hyperTD (n = 6 eyes)\nMedium hyperTD (n = 11 eyes)\nLarge hyperTD (n = 7 eyes)\n\nP-value\n\n\n\nStable, No. (%)\n108 (89.3)\n0 (0)\n1 (9.1)\n1 (14.3)\n<0.001\n\n\nProgression to or development of iRORA or cRORA, No. (%)\n13 (10.7)\n5 (83.3)\n9 (81.8)\n6 (85.7)\n\n\nRegression, No. (%)\nNA\n1 (16.7)\n1 (9.1)\n0 (0)\n\n\n\nOpen in a new tab\ncRORA complete retinal pigment epithelial and outer retinal atrophy, GLD greatest linear dimension, hyperTD hypertransmission defect, iRORA incomplete retinal pigment epithelial and outer retinal atrophy, large hyperTD GLD ≥ 250 µm, medium hyperTD GLD 125–249 µm, NA not available, No. number, small hyperTD GLD 63–124 µm.Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "This eye is deemed a progression eye.Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 2,
    "claims_count": 20,
    "images_downloaded": 2,
    "tables_filtered": 62
  }
}